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Background: Beta-palmitate (sn-2 palmitate) mimics human milk fat, enabling easier digestion.
Therefore, we hypothesized that infants consuming high beta-palmitate formula would have more frequent, softer
stools and reduced crying compared to infants consuming low beta-palmitate formula.
Methods: Formula-fed infants were randomly assigned to receive either (1) formula with high beta-palmitate (HBP,
n = 21) or (2) regular formula with a standard vegetable oil mix (LBP, n = 21). A matched group of breastfed infants
served as a reference (BF, n = 21). Crying and stool characteristics data were recorded by the parents for 3 days
before the 6- and 12-week visits.
Results: We found no significant differences in the stool frequency or consistency between the two formula
groups. The percentage of crying infants in the LBP group was significantly higher than that in the HBP and BF
groups during the evening at 6 weeks (88.2% vs. 56.3% and 55.6%, p < 0.05) and during the afternoon at 12 weeks
(91.7% vs. 50.0% and 40%, p < 0.05). The infants fed HBP had significantly shorter crying durations when compared
with infants fed LBP formula (14.90 ± 3.85 vs.63.96 ± 21.76 min/day, respectively; p = 0.047).
Conclusions: Our study indicates that consumption of a high beta-palmitate formula affects infant crying patterns
during the first weeks of life. Comparable to breastfeeding, it reduced crying duration and frequency, primarily
during the afternoon and evening hours, thereby improving the well-being of formula-fed infants and their parents.
Trial registration: NCT00874068.
Registration date March 31, 2009
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Crying is a basic, instinctive response governed by basic
neuro-chemical mechanisms that are similar to those
that control feeding [1]. Although crying is a common
spontaneous behavior, it can induce parental concern,
which often results in requests for assistance from health
services [1]. Most infants follow a universal crying pat-
tern during the first few months of life, in which crying
peaks at 6 weeks of age and then declines until 3 months* Correspondence: litmani@clalit.org.il
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article, unless otherwise stated.of age [1-6]. Crying also has a typical diurnal pattern:
40% of crying episodes occur between 1600 and 2200 h,
and after the third month of life, crying episodes are
more distributed throughout the day. Infant crying is
usually believed to be related to abdominal discomfort,
whereas crying for more than 3 hours per day (cumula-
tive), without relation to a medical problem, is termed
infantile colic [7]. The prevalence of abdominal discom-
fort, colic, and their associated potential effects demon-
strates the importance of identifying determinants of
infant crying behavior, particularly for determinants that
can be modified (e.g., feeding choice) [2].
Human milk is the optimal choice for the vast majority
of infants. In human breast milk and most infantntral Ltd. This is an Open Access article distributed under the terms of the
/creativecommons.org/licenses/by/2.0), which permits unrestricted use,
, provided the original work is properly credited. The Creative Commons Public
mons.org/publicdomain/zero/1.0/) applies to the data made available in this
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from fat, with more than 98% in the form of triglycerides
(TGs) [8,9]. Infants easily absorb human milk fat despite
its high content of saturated fatty acids (45% of total fatty
acids), primarily palmitic acid (C16:0), of which 70-75% is
esterified at the sn-2 (beta) position of the TG [8]. This
configuration is characterized by a unique, highly specific,
positional distribution on the glycerol backbone observed
only in TG synthesis in the mammary gland [10]. Studies
have shown that palmitic acid is absorbed from human
milk as an sn-2 monoacylglycerol [11] and is conserved in
that form through digestion, absorption, and chylomicron
triacylglycerol synthesis [12]. In contrast, palmitic acid,
which is present in the vegetable oils that are commonly
used in the manufacturing of infant formulas, is mainly
(>80%) esterified to the sn-1 and sn-3 positions [13] and is
therefore poorly absorbed by an infant’s intestine. The
main cause of this low absorption is the high tendency of
palmitic acid esterified at the sn-1 and sn-3 positions to
create complexes with dietary minerals, such as calcium
[14]. These complexes, known as fatty acid soaps, are
insoluble, indigestible, and positively related to stool
hardness [15]. The formation of calcium soaps may
partly explain the substantial differences in bowel habits
and stool consistency between breast- and formula-fed
infants [15-17].
The goal of this study was to compare the effects of
high-sn-2 palmitate (beta-palmitate) and low-sn-2 palmi-
tate formulas on infant crying patterns and stool charac-
teristics. We hypothesized that infants who consumed
high beta-palmitate formula would demonstrate reduced
crying and more frequent, softer stools compared to in-
fants consuming low beta-palmitate formula.
Methods
Subjects and study design
The study was a single-center, randomized, double-blind,
placebo-controlled study [18]. Healthy term infants whose
weights were appropriate for gestational age (AGA) were
eligible for the study. Infants were excluded from the
study if they had been diagnosed with congenital, chromo-
somal, or metabolic disorders. Subjects were enrolled
within their first 2 weeks of life to one of two formula
groups if their mother made an unequivocal decision not
to breastfeed or to a matched reference group of term
breastfed infants. Parents provided written informed
consent prior to enrollment. Formula-fed infants were
randomly assigned (using a computerized automatic ran-
domization system) to receive either (1) formula with a
high level of beta-palmitate (HBP group) consisting of
44% of palmitic acids esterified at the midpoint position of
the glycerol backbone (INFAT®, Advanced Lipids) or (2) a
regular infant formula (LBP Control group) with a stan-
dard vegetable oil mix consisting of 14% of palmitic acidsesterified to the midpoint position of the glycerol back-
bone. Both of the preparations were commercial formulas
produced by Materna Laboratories (Maabarot, Israel)
under the same conditions using minerals and vitamins
from the same batches, resulting in formulas that were
identical except for their fatty acid structural distribution.
Formulas were packed in identical and unmarked boxes,
and the personnel caring for the infants and mothers were
blinded to their contents. The formulas did not contain
pre- or probiotic components.
This study was conducted according to the principles
of the Declaration of Helsinki and good clinical practice.
The protocol was approved by the Ethics Committee of
Meir Medical Center, Kfar-Saba, Israel, and by the Israeli
Ministry of Health.
Anthropometric measurements
Anthropometric measurements, performed at birth and at
6 and 12 weeks, by a trained technician (who was blinded
to the study group assignment) included the following:
Body Weight: the mean of three measurements on an
electronic infant scale (Model 20 Tabletop Infant Scale,
Olympic Medical, Seattle, WA).
Body Length: the mean of two measurements of re-
cumbent crown-heel length on a length board (O’Leary
Premier Length Board, Ellard Instrumentation Ltd.,
Monroe, WA) to the nearest 0.1 cm.
Head Circumference: fronto-occipital head circum-
ference measured with a standard 1-cm wide measuring
tape to the nearest 0.1 cm.
Parent questionnaires
Data on crying and stool characteristics were reported by
the parents, who used 24-hr behavior diaries for 3 days
before the infants’ 6- and 12-week visits. The reports also
included (1) the volume of formula used in feedings and
(2) stool characteristics, including color (yellow, green,
brown, and black), frequency and consistency (hard, mu-
shy, or watery). Crying episodes of more than 5 minutes
were reported. The parents reported the duration, time of
the day, and their assumption of what caused the crying.
The mean number of crying periods per day, the mean
crying duration per day, and the pattern of crying during
the day were calculated. The pattern of crying during the
day was analyzed at 6 and 12 weeks by calculating the per-
centage of crying infants and the total length of crying
during each 6-hour period of the day, where morning =
6 am–noon, afternoon = noon–6 pm, evening = 6 pm–
midnight, and night =midnight–6 am.
Statistical analysis
The baseline characteristics of the mothers and infants
in the HBP and LBP formula groups were compared
with pairwise t-tests for scale outcomes and pairwise
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rameters were tested at 6 and 12 weeks for all infants
using the available accurate crying data at each time
point. All parameters of the formula groups were com-
pared to those of the BF group (for reference). Statistical
analyses were conducted with SPSS v20 (SPSS, Inc.,
Chicago, IL). The data are expressed as the means ±
SEMs. Statistical significance was inferred at p < 0.05.Results
Study population
Between March 2009 and Nov 2011, eighty-three infants
born at the Meir Medical Center were enrolled in the
study, including 58 formula-fed infants and 25 exclusively
breastfed infants. The formula-fed infants were randomly
assigned to receive either HBP formula (n = 30) or LBP
formula (n = 28). The attrition rate at the end of the study
period was 21%, and it was equally distributed between
the three groups (Figure 1); the sample of non-completers
was matched to those who completed the study.
The maternal and infant baseline characteristics are pre-
sented in Table 1. No significant differences were observed
between the two formula groups; however, the breast-
feeding mothers had significantly higher education levels
(>12 years). The infants in the breastfed group were born
at a significantly greater gestational age. Moreover, the
infants in the breastfed group were all singletons, whereas
twins represented 21.4% and 26.7% of the infants in the
LBP and HBP formula groups, respectively. The mean
formula consumption was comparable between the two
formula groups both at 6 weeks (177 vs. 178 ml/kg/day, in
the HBP and LBP groups, respectively) and at 12 weeks
(143 vs. 139 ml/kg/day).Figure 1 Participant flow diagram.Anthropometric data at baseline and at 6 and 12 weeks
postnatal are presented in Table 2. All infants maintained
normal growth throughout the study period, and by the
end of the study (i.e., 12 weeks postnatal), no significant dif-
ferences were observed between the groups. No significant
differences were found between the two formula-fed groups
in mean weight, length, and head circumference during the
study visits (baseline and 6 and 12 weeks postnatal).
Stool characteristics
Stool characteristics were evaluated at 6 and 12 weeks
postnatal based on the 3-day diaries completed by parents
prior to each visit (Table 3). Stool characteristics were
evaluated according to the mean number of stools per
day, stool consistency (1 = hard, 2 = soft, 3 = watery), and
the percentage of infants who had hard stools.
The BF infants had significantly higher stool frequencies
(mean no. of stools per day) than the infants in both the
HBP and LBP formula groups at both 6 weeks postnatal
(3.8, 2.0, and 2.4, respectively, p < 0.05) and 12 weeks post-
natal (3.2, 1.6, and 1.4, respectively, p < 0.01). The breast-
fed infants also had softer stools, with significantly higher
mean stool consistency scores at both 6 weeks postnatal
(2.4, 1.9, and 1.9, respectively, p < 0.05) and 12 weeks post-
natal (2.4, 2.0, and 2.0, respectively, p < 0.05). No signifi-
cant differences in stool frequencies or consistencies were
observed between the two formula groups. At 6 weeks,
hard stools were reported for only 5% of the BF infants,
compared with 16.7% and 23.1% of the infants in the LBP
and HBP groups, respectively. At 12 weeks, however, a
significant reduction in hard stools was observed for the
HBP group but not the LBP group, and the difference
remained significant only between the BF group and the
LBP group (0.0% vs. 23.8%, p = 0.023; Table 3).
Table 1 Baseline maternal and infant demographic
characteristics
LBP HBP BF
(n = 28) (n = 30) (n = 25)
Maternal age, years 33.3 ± 0.8 32.3 ± 0.6 31.6 ± 0.8
Maternal education
(% of women with >12 years
of education)
53.6%* 60.0%* 92.0%
Primigravida (%) 21.4% 16.7% 32.0%
Gestational age, weeks 39.1 ± 0.2* 39.1 ± 0.2* 39.7 ± 0.2
Type of delivery (% vaginal) 57.1% 72.4% 68.0%
Twins (%) 21.4%* 26.7%* 0.0%
Gender (% male) 46.4% 60.0% 68.0%
Birth weight, kg 3.2 ± 0.5 3.1 ± 0.6 3.4 ± 0.4
Mean ± SEM.
*p < 0.05 compared to BF.
Table 3 Stool characteristics at 6 and 12 weeks postnatal
LBP HBP BF
6 weeks
Stools per day 2.0 ± 0.2* 2.4 ± 0.3* 3.8 ± 0.5
Stool consistency score 1.9 ± 0.1* 1.9 ± 0.0* 2.4 ± 0.1
Percent of infants with hard stools 16.7% 23.1% 5.0%
12 weeks
Stools per day 1.6 ± 0.2* 1.4 ± 0.1* 3.2 ± 0.5
Stool consistency score 2.0 ± 0.1* 2.0 ± 0.1* 2.4 ± 0.1
Percent of infants with hard stools 23.8%* 14.3% 0.0%
Mean ± SEM or percent.
*p < 0.05 compared to BF.
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Figure 2 shows the percentages of infants with reported
crying events at each period of the day. The percent of
crying infants peaked in the afternoon-evening and de-
clined at night. The crying pattern in the HBP group
was comparable to that of the BF group at both 6 and
12 weeks. The percentage of crying infants in the LBP
group was higher than that of both the HBP and the BF
groups during the evening at 6 weeks (88.2% vs. 56.3%
and 55.5%, respectively; p < 0.05) and during the after-
noon at 12 weeks (91.7% vs. 50.0% and 40%, respectively;
p < 0.05).
At 12 weeks, the total duration of crying in HBP infants
was comparable to that of BF infants. Infants consuming
LBP formula had a significantly longer mean total crying
duration when compared to the HBP infants (63.96 ±Table 2 Anthropometric parameters measured at baseline
and at 6 and 12 weeks postnatal
LBP HBP BF
Baseline
Weight (Kg) 3.1 ± 0.1 3.0 ± 0.1 3.2 ± 0.1
Length (cm) 49.1 ± 0.4 49.2 ± 0.5 50.3 ± 0.5
Head circumference (cm) 34.1 ± 0.3 34.0 ± 0.3* 34.9 ± 0.3
6 weeks
Weight (Kg) 4.6 ± 0.1* 4.6 ± 0.1* 5.0 ± 0.1
Length (cm) 55.0 ± 0.5* 55.1 ± 0.5* 56.8 ± 0.5
Head circumference (cm) 37.3 ± 0.4* 37.3 ± 0.3* 38.3 ± 0.2
12 weeks
Weight (Kg) 5.9 ± 0.2 5.9 ± 0.2 6.2 ± 0.2
Length (cm) 59.8 ± 0.5 59.8 ± 0.6 60.1 ± 0.4
Head circumference (cm) 40.1 ± 0.3 39.5 ± 0.4 39.9 ± 0.4
Mean ± SEM.
*p < 0.05 compared to BF.21.76 vs. 14.90 ± 3.85 min/day; p = 0.047; Figure 3). Infants
in the HBP group cried less frequently than infants in the
LBP group at 12 weeks postnatal (0.3 vs. 0.8 periods/day,
p = 0.028).
Discussion
This randomized controlled study showed that term in-
fants who consumed formula with a high beta-palmitate
content (HBP) cried less than infants who consumed LBP
formula. Additionally, the study showed that the con-
sumption of formula with beta- palmitate improved infantFigure 2 Diurnal pattern of crying in LBP formula-fed, HBP
formula-fed, and breastfed infants at 6 (Upper panel) and 12
(Lower panel) weeks postnatal.
Figure 3 Total daily crying in LBP formula-fed, HBP formula-fed,
and breastfed infants at 12 weeks of age. Data are means ±
standard error.
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patterns in the HBP group were comparable to those of
breastfed infants, and the percentage of crying infants was
significantly lower in the HBP group than in the LBP
group during the evening and night hours.
Previous studies have shown that the daily duration of
crying and fussing in infants increases until 6 weeks of age
and then decreases progressively [1-6,19]. Our study
showed similar peaks of daily crying at 6 weeks for all
groups. Harrison et al. found a 50% reduction in daily
crying duration from 6 to 12 weeks [20]; however, in their
study, the type of feeding was not specified. Our study
revealed a similar reduction in daily crying duration, both
in the BF group (50%) and the HBP group (80%). In con-
trast, a small increase in crying time was observed in the
LBP group.
Crying commonly clusters in the afternoon and even-
ing [21,22]. We also observed this peak in this study for
all three groups; however, we found that infants in the
HBP group cried less during the afternoon and evening
hours and had significantly greater reductions in crying
duration in the afternoon between 6 and 12 weeks
postnatal.
The effects of breastfeeding versus formula feeding on
infant crying are controversial. Many studies support
breastfeeding as an effective method of calming infants
due to its emotional impacts [23]. Kennedy et al. [16]
monitored crying duration in infants who consumed for-
mula containing high versus low levels of beta-palmitate.
In contrast to our study, they did not find differences in
crying between the groups. Savino et al. [24] evaluated
the efficacy of formula that was partially hydrolyzed withprebiotic oligosaccharides (OSs) and contained a high
level of beta palmitate. The authors found significant dif-
ferences in crying that were primarily due to a signifi-
cant reduction in the afternoon crying duration between
6 and 12 weeks postnatal. In their study, however, the
formulas contained several different components (par-
tially hydrolyzed whey proteins, prebiotic OSs, and beta
palmitate); therefore, the relative contribution of the
HBP component could not be determined.
Crying behavior in infants is a complex phenomenon
that includes spontaneous "endogenous" crying and “dis-
tress-related” crying, which can be linked to separation,
hunger, or other physical distresses; therefore, several
mechanisms can explain the positive effect of HBP on
crying. One mechanism can be attributed to the effect that
HBP has on stool characteristics. In this study, HBP-fed
infants demonstrated more favorable stool characteristics
than LBP-fed infants at 12 weeks. Improvement of stool
characteristics is one of the well-known benefits of beta-
palmitate [16,25,26]. In a previous study, we showed that
high beta-palmitate formula beneficially affected infant
gut microbiota by increasing the lactobacillus and bifido-
bacteria counts in stools [27]. This is another possible
mechanism because changes in gut microflora induced by
probiotic supplementation likely improve infant colic [21].
Animal studies suggest that diet can alter endogenous
crying by modifying neuro-endocrine metabolism in the
gut (e.g., through the endocannabinoid system, which is
associated with a variety of functions, including pain and
circadian rhythm). Using a rat model, Banni et al. [27]
showed that a diet rich in beta-palmitate led to higher
efficiency and enhanced endocannabinoid biosynthesis.
One possible limitation of our study is that we relied
on the parents to record crying measurements. Parent
diaries of infant crying have become the standard and
most widely used tool for studying infant crying [1,28];
however, this method is still subjective and requires a
high degree of parental cooperation. In this study, this
limitation was partially overcome by the double-blind
nature of our study. We were also limited in this study
because crying is known to be highly affected by an
infant’s temperament [2], which could have biased our
results. We could not, however, overcome this limitation
because we did not assess the temperaments of the
infants included in this study.
Conclusions
Our study indicates that high beta-palmitate (sn-2 palmi-
tate) formula affects infant crying patterns during the first
weeks of life. Comparable to breastfeeding, high beta-
palmitate reduced crying duration and frequency, pri-
marily during the afternoon and evening hours, thereby
improving the well-being of formula-fed infants and their
parents.
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